Nicotine Gum Market is driven by rising awareness of smoking cessation Nicotine gum is a chewing gum that delivers nicotine to the body to relieve or reduce withdrawal symptoms when trying to quit smoking. It works by releasing nicotine slowly into the bloodstream through the lining of the mouth as the gum is chewed. Nicotine gum provides a low level of nicotine without any combustion, smoke, or other components present in tobacco products. It is often used as an aid in smoking cessation programs. Nicotine replacement therapies including nicotine gum help smokers reduce smoking urges and nicotine cravings. Global Nicotine Gum Market is estimated to be valued at USD 2.04 Bn in 2025 and is expected to reach USD 3.37 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032. Key Takeaways Key players operating in the nicotine gum market are Pfizer Inc., Novartis International AG, GlaxoSmithKline Plc., Fertin Pharma, Perrigo Company plc. Key players are mainly focusing on increasing awareness regarding smoking cessation and benefits of nicotine gum. The Nicotine Gum Market Demand is growing owing to increasing prevalence of smoking and growing awareness regarding risks associated with smoking. Various initiatives undertaken by governments and healthcare organizations to promote smoking cessation are further driving the demand for nicotine gum. Nicotine Gum Market-https://www.coherentmarketinsights.com/industry-reports/nicotine-gum-market